MacroGenics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
MGNX Key Statistics
Stock Snapshot
MacroGenics(MGNX) stock is priced at $1.40, giving the company a market capitalization of 88.25M. It carries a P/E multiple of -1.14.
During the trading session on 2025-11-21, MacroGenics(MGNX) shares reached a daily high of $1.42 and a low of $1.33. At a current price of $1.40, the stock is +5.3% higher than the low and still -1.4% under the high.
Trading activity shows a volume of 731.77K, compared to an average daily volume of 1.08M.
Over the past 52 weeks, MacroGenics(MGNX) stock has traded between a high of $3.77 and a low of $0.99.
Over the past 52 weeks, MacroGenics(MGNX) stock has traded between a high of $3.77 and a low of $0.99.
MGNX News
TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to Tip...
MacroGenics Inc ( (MGNX) ) has released its Q3 earnings. Here is a breakdown of the information MacroGenics Inc presented to its investors. Meet Your ETF AI An...